{
    "clinical_study": {
        "@rank": "61953", 
        "arm_group": {
            "arm_group_label": "Cryoablation", 
            "arm_group_type": "Other", 
            "description": "Cryoablation"
        }, 
        "brief_summary": {
            "textblock": "Primary Endpoint Safety and tolerability of ablation using the AFreeze Cryoablation System\n      consisting of the ablation CoolLoop\u00ae catheter, its steerable sheath and the cryoconsole\n      Cryo-Caddy will be assessed and expressed in number of participants with Adverse Events\n      (AEs)."
        }, 
        "brief_title": "Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "Cryoablation\nCryoablation : Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System", 
                        "title": "Cryoablation"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "10"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "8"
                                            }
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "2"
                                            }
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "7.6", 
                                            "@value": "57.6"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "4"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "6"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "10"
                                        }
                                    }, 
                                    "sub_title": "Austria"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "Following approval of the Sponsor and before publishing or presenting data related to the Trial or the Device, Research lnstitution, Principal lnvestigator, and Co-lnvestigator agree to submit copies of any and all proposed manuscripts or abstracts to Sponsor at least 30 days in advance of the date that the applicable party proposes to submit such proposed manuscripts or abstracts to a publisher or other third party."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "The primary study objective is assessed by recording all Serious Adverse Events (SAEs).\nPrimary endpoint: measurement of the following parameters:\ndeformation of the catheter loop resulting in entrapment of the catheter in the heart and difficulties removing the catheter during visit 3 (treatment).\nphrenic nerve palsy during visit 3 (treatment).\nonset and time course between visit 3 (treatment) and visit 5 (discharge) of death, pericardial tamponade, valve damage requiring surgery and hemorrhage requiring transfusion.\nonset and time course between visit 3 (treatment) and visit 9 (final visit) of atrioesophageal fistula, sepsis, abscesses, endocarditis, stroke, transient ischemic attack, and PV stenosis requiring intervention.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Cryoablation\nCryoablation : Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System", 
                                "title": "Cryoablation"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "10"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "6"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "The primary study objective is assessed by recording all Serious Adverse Events (SAEs).\nPrimary endpoint: measurement of the following parameters:\ndeformation of the catheter loop resulting in entrapment of the catheter in the heart and difficulties removing the catheter during visit 3 (treatment).\nphrenic nerve palsy during visit 3 (treatment).\nonset and time course between visit 3 (treatment) and visit 5 (discharge) of death, pericardial tamponade, valve damage requiring surgery and hemorrhage requiring transfusion.\nonset and time course between visit 3 (treatment) and visit 9 (final visit) of atrioesophageal fistula, sepsis, abscesses, endocarditis, stroke, transient ischemic attack, and PV stenosis requiring intervention.", 
                                    "param": "Number", 
                                    "title": "Safety of Ablation Using the AFreeze Cryoablation System Consisting of the CoolLoop\u00ae Ablation Catheter, Its Steerable Sheath and the Cryoconsole Cryo-Caddy Assessed by Recording All Serious Adverse Events (SAEs)", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "3 months", 
                        "title": "Safety of Ablation Using the AFreeze Cryoablation System Consisting of the CoolLoop\u00ae Ablation Catheter, Its Steerable Sheath and the Cryoconsole Cryo-Caddy Assessed by Recording All Serious Adverse Events (SAEs)", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "The primary study objective is assessed by recording all Adverse Events (AEs).\nPrimary endpoint: measurement of the following parameters:\n- deformation of the catheter loop resulting in entrapment of the catheter in the heart and difficulties removing the catheter during visit 3 (treatment).", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Cryoablation\nCryoablation : Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System", 
                                "title": "Cryoablation"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "10"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "1"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "The primary study objective is assessed by recording all Adverse Events (AEs).\nPrimary endpoint: measurement of the following parameters:\n- deformation of the catheter loop resulting in entrapment of the catheter in the heart and difficulties removing the catheter during visit 3 (treatment).", 
                                    "param": "Number", 
                                    "title": "Tolerability of Ablation Using the AFreeze Cryoablation System", 
                                    "units": "AE (device related)"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "Treatment Duration", 
                        "title": "Tolerability of Ablation Using the AFreeze Cryoablation System", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Feasibility, defined by the ability to position the catheter in the proximal part in each of the pulmonary veins (PVs) using an over-the-wire technique, forming the cryo-applicator of the catheter to a loop by operating the catheter handle, positioning the loop at the wall of the PV antrum and delivering cryothermia.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Cryoablation\nCryoablation : Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System", 
                                "title": "Cryoablation"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "10"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "10"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Feasibility, defined by the ability to position the catheter in the proximal part in each of the pulmonary veins (PVs) using an over-the-wire technique, forming the cryo-applicator of the catheter to a loop by operating the catheter handle, positioning the loop at the wall of the PV antrum and delivering cryothermia.", 
                                    "param": "Number", 
                                    "title": "Feasibility of Catheter Ablation Measured by Number of Participants Treated With the AFreeze Cryoablation System.", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Treatment Duration", 
                        "title": "Feasibility of Catheter Ablation Measured by Number of Participants Treated With the AFreeze Cryoablation System.", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Absolute percentage of PVs isolated with the CoolLoop\u00ae catheter.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Cryoablation\nCryoablation : Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System", 
                                "title": "Cryoablation"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "10"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "57.5"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Absolute percentage of PVs isolated with the CoolLoop\u00ae catheter.", 
                                    "param": "Number", 
                                    "title": "Acute Efficacy of Catheter Ablation", 
                                    "units": "percentage of isolated PVs"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Treatment Duration", 
                        "title": "Acute Efficacy of Catheter Ablation", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "During follow-up recurrence of AF was reported by the patient and documented by ECG in 8 patients (80%). 2 patients remained free of recurrences of AF.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Cryoablation\nCryoablation : Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System", 
                                "title": "Cryoablation"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "10"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "2"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "During follow-up recurrence of AF was reported by the patient and documented by ECG in 8 patients (80%). 2 patients remained free of recurrences of AF.", 
                                    "param": "Number", 
                                    "title": "Clinical Efficacy of Catheter Ablation", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "First patient - first visit: September 11, 2012; Last patient - last visit: March 26, 2013", 
                        "title": "Clinical Efficacy of Catheter Ablation", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Procedure time was defined from introduction of the CoolLoop\u00ae catheter into the left atrium until removal of the CoolLoop\u00ae catheter from the left atrium after termination of the last cryo-application.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Cryoablation\nCryoablation : Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System", 
                                "title": "Cryoablation"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "10"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "59.7", 
                                                    "@value": "251.1"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Procedure time was defined from introduction of the CoolLoop\u00ae catheter into the left atrium until removal of the CoolLoop\u00ae catheter from the left atrium after termination of the last cryo-application.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Procedure Time", 
                                    "units": "minutes"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Average procedure time: 251 min. 06 sec. (range 126 \u2013 320 min.)", 
                        "title": "Procedure Time", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Fluoroscopy time was defined from introduction of the CoolLoop\u00ae catheter into the left atrium until removal of the CoolLoop\u00ae catheter from the left atrium after termination of the last cryo - application. Accumulated time using fluoroscopy during procedure time.\nAverage fluoroscopy time was 44 min. 01 sec. (range 17 min. 03 sec. \u2013 59 min.).", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Cryoablation\nCryoablation : Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System", 
                                "title": "Cryoablation"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "10"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "13.2", 
                                                    "@value": "44"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Fluoroscopy time was defined from introduction of the CoolLoop\u00ae catheter into the left atrium until removal of the CoolLoop\u00ae catheter from the left atrium after termination of the last cryo - application. Accumulated time using fluoroscopy during procedure time.\nAverage fluoroscopy time was 44 min. 01 sec. (range 17 min. 03 sec. \u2013 59 min.).", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Fluoroscopy Time", 
                                    "units": "minutes"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Treatment Duration", 
                        "title": "Fluoroscopy Time", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Cryoablation time was defined as the cumulative duration of all cryoapplications in each single study patient.\nAverage cryoablation time was 114 min. 33 sec. (range 80 \u2013 130 min.).", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Cryoablation\nCryoablation : Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System", 
                                "title": "Cryoablation"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "10"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "18.1", 
                                                    "@value": "113.9"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Cryoablation time was defined as the cumulative duration of all cryoapplications in each single study patient.\nAverage cryoablation time was 114 min. 33 sec. (range 80 \u2013 130 min.).", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Cumulative Cryoablation Time", 
                                    "units": "minutes"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "First patient - first visit: September 11, 2012; Last patient - last visit: March 26, 2013", 
                        "title": "Cumulative Cryoablation Time", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "18 AEs were recorded in 7 out of 10 patients. 3 AEs were definitely related to treatment and one AE was definitely device related. All patients recovered completely.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Cryoablation\nCryoablation : Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System", 
                                "title": "Cryoablation"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "10"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "7"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "18 AEs were recorded in 7 out of 10 patients. 3 AEs were definitely related to treatment and one AE was definitely device related. All patients recovered completely.", 
                                    "param": "Number", 
                                    "title": "AE", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "First patient - first visit: September 11, 2012; Last patient - last visit: March 26, 2013", 
                        "title": "AE", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "Cryoablation\nCryoablation : Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System (single treatment during visit 3).", 
                        "title": "Cryoablation"
                    }
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "10", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "10", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "0", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "not applicable", 
                "recruitment_details": "Recruitment period: September 3,2012 - December 14, 2012 Locations: Medical University Innsbruck, General Hospital Linz"
            }, 
            "point_of_contact": {
                "email": "markus.stuehlinger@uki.at", 
                "name_or_title": "Markus St\u00fchlinger, MD", 
                "organization": "Medical University Innsbruck, Department of Internal Medicine III, Cardiology", 
                "phone": "+43 512 504 ext 81 320"
            }, 
            "reported_events": {
                "desc": "Patients were closely followed for adverse events during treatment and within the defined follow up period according to the study protocol. All Adverse Events including intercurrent disease had to be documented in the patient\u2019s medical file and subsequently in the case report form.", 
                "group_list": {
                    "group": {
                        "@group_id": "E1", 
                        "description": "Cryoablation\nCryoablation : Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System", 
                        "title": "Cryoablation"
                    }
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "7", 
                                            "@subjects_at_risk": "10"
                                        }, 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Non-systematic Assessment", 
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "10"
                                        }, 
                                        "description": "anemia due to art. bleeding", 
                                        "sub_title": "anemia"
                                    }
                                }, 
                                "title": "Blood and lymphatic system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@events": "2", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "10"
                                            }, 
                                            "description": "recurrent atrial fibrillation", 
                                            "sub_title": "atrial fibrillation"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "2", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "10"
                                            }, 
                                            "description": "Hospitalization due to recurrent atrial fibrillation", 
                                            "sub_title": "Hospitalization"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "10"
                                            }, 
                                            "sub_title": "dyscardia"
                                        }
                                    ]
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Non-systematic Assessment", 
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "10"
                                        }, 
                                        "sub_title": "hyperthyreosis factitis"
                                    }
                                }, 
                                "title": "Endocrine disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Non-systematic Assessment", 
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "10"
                                        }, 
                                        "sub_title": "burning eyes"
                                    }
                                }, 
                                "title": "Eye disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Non-systematic Assessment", 
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "10"
                                        }, 
                                        "sub_title": "dyspepsia"
                                    }
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Non-systematic Assessment", 
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "10"
                                        }, 
                                        "sub_title": "dizzyness"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "10"
                                            }, 
                                            "description": "neck pain (Mb. Bechterew)", 
                                            "sub_title": "neck pain"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": {
                                                "@events": "3", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "10"
                                            }, 
                                            "description": "back pain", 
                                            "sub_title": "back pain"
                                        }
                                    ]
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Non-systematic Assessment", 
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "10"
                                        }, 
                                        "description": "Catheter loop not retractable to straight position; catheter could be retracted after \"rescue maneuver\" as defined in the system's user manual.", 
                                        "sub_title": "catheter loop not retractable to straight position"
                                    }
                                }, 
                                "title": "Surgical and medical procedures"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "10"
                                            }, 
                                            "description": "air embolism (after introduction of investigational device into left atrium ST-Elevation in ECG observed; transient Hypotension)", 
                                            "sub_title": "air embolism"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "10"
                                            }, 
                                            "sub_title": "groin hematoma with art. bleeding"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "10"
                                            }, 
                                            "description": "intermittent ST elevation (susp. air embolism). ST elevation: finding on an electrocardiogram, wherein the trace in the ST segment is abnormally high above the isoelectric line.", 
                                            "sub_title": "intermittent ST elevation"
                                        }
                                    ]
                                }, 
                                "title": "Vascular disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "CTCAE V4.03 (NCI)", 
                    "frequency_threshold": "1"
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "6", 
                                            "@subjects_at_risk": "10"
                                        }, 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "5", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "5", 
                                            "@subjects_at_risk": "10"
                                        }, 
                                        "description": "Hospitalization due to recurrent atrial fibrillation.", 
                                        "sub_title": "Hospitalization"
                                    }
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Non-systematic Assessment", 
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "10"
                                        }, 
                                        "description": "Groin hematoma with arterial bleeding from arteria femoralis sin. during puncture of vena femoralis sin. Bleeding stopped by surgical Intervention.", 
                                        "sub_title": "groin hematoma"
                                    }
                                }, 
                                "title": "Surgical and medical procedures"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "CTCAE V4.03 (NCI)"
                }, 
                "time_frame": "First patient - first visit: September 11, 2012; Last patient - last visit: March 26, 2013 (6 months and 15 days)"
            }
        }, 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Atrial Fibrillation", 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "detailed_description": {
            "textblock": "Therefore, the primary endpoint will be a measurement of the following parameters and\n      expressed in number of participants with AE:\n\n        -  deformation of the catheter loop resulting in entrapment of the catheter in the heart\n           and difficulties removing the catheter during visit 3 (treatment)\n\n        -  phrenic nerve palsy during visit 3 (treatment)- onset and time course between visit 3\n           (treatment) and visit 5 (discharge) of death, pericardial tamponade, valve damage\n           requiring surgery and hemorrhage requiring transfusion.\n\n        -  onset and time course between visit 3 (treatment) and visit 9 (final visit) of\n           atrioesophageal fistula, sepsis, abscesses, endocarditis, stroke, transient ischemic\n           attack, and pulmonary vein (PV) stenosis requiring intervention.\n\n      Secondary Endpoint\n\n      The following parameters will be assessed and expressed in number of participants with\n      AE/duration time:\n\n        -  feasibility, defined by the ability to position the catheter in the proximal part in\n           each of the PVs using an over-the-wire technique, forming the cryo-applicator of the\n           catheter to a loop by operating the catheter handle, position-ing the loop at the wall\n           of the PV antrum and delivering cryothermia.\n\n        -  acute efficacy of catheter ablation is defined as the percentage of electrodes within\n           the PV without measureable signals.\n\n        -  clinical efficacy of catheter ablation defined by freedom of Atrial Fibrillation (AF)\n           four, eight and twelve weeks after ablation.\n\n        -  procedure time defined from introduction of the CoolLoop\u00ae catheter into the left atrium\n           until removal of the CoolLoop\u00ae catheter from the left atrium after termination of the\n           last cryoapplication.\n\n        -  fluoroscopy time defined from introduction of the CoolLoop\u00ae catheter into the left\n           atrium until removal of the CoolLoop\u00ae catheter from the left atrium after termination\n           of the last cryoapplication.\n\n        -  cumulative cryoablation time.\n\n        -  onset and time course between visit 3 (treatment) and visit 5 (discharge) of\n           pneumothorax, hemothorax, femoral pseudoaneurysm, arteriovenous fistulae, hemorrhage\n           not requiring transfusion."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age 18 - 70 years\n\n          -  symptomatic paroxysmal AF, according to the actual guidelines of the Eu-ropean\n             Society of Cardiology, despite treatment with at least one antiarr- hythmic drug\n\n          -  at least one episode of AF within the last 3 months documented by ECG\n\n          -  signed and dated informed consent documented by the patient, indicating that the\n             patient has been informed of all the pertinent aspects of the trial prior to study\n             enrollment\n\n          -  female subjects of childbearing potential can be included, if they: agree to use, and\n             be able to comply with, effective contraception without in-terruption, from study\n             enrollment, throughout hospitalization and until 12 weeks after catheter ablation\n             (day 0, visit 3). This applies unless the subject commits to absolute and continued\n             abstinence. The following are effective methods of contraception:\n\n          -  Implant,\n\n          -  Levonorgestrel-releasing intrauterine system (IUS),\n\n          -  Medroxyprogesterone acetate depot,\n\n          -  Tubal sterilization,\n\n          -  Sexual intercourse with a vasectomized male partner only; vasectomy must be confirmed\n             by two negative semen ana-lyses,\n\n          -  Ovulation inhibitory progesterone-only pills (i.e., desoge-strel). (Combined oral\n             contraceptive pills are not recommended. If a subject was using combined oral\n             contraception, she must switch to one of the methods above. The increased risk of\n             venous thromboembolism (VTE) continues for 4 to 6 weeks after stopping combined oral\n             contraception.\n\n        Exclusion Criteria:\n\n          -  left atrial diameter > 50 mm as assessed by transthoracic echocardiogra-phy,\n\n          -  electrical cardioversion performed later than seven days after onset of AF,\n\n          -  advanced structural heart disease including\n\n          -  moderate-to-severe valvular stenosis or regurgitation,\n\n          -  previous myocardial infarction with impaired left ventricular systolic function,\n\n          -  congenital heart disease,\n\n          -  left ventricular ejection fraction < 45% during sinus rhythm,\n\n          -  coronary artery bypass graft surgery within the last 3 months.\n\n          -  chronic obstructive pulmonary disease treated with beta-sympathomimetic drugs,\n\n          -  severe respiratory insufficiency,\n\n          -  known bleeding diathesis or intolerance of heparin or oral anticoagulation,\n\n          -  previous AF ablation,\n\n          -  left atrial thrombus,\n\n          -  severe comorbidity,\n\n          -  hyperthyreosis,\n\n          -  any condition, including the presence of laboratory abnormalities, which would place\n             the subject at unacceptable risk if he / she were to participate in the study or\n             confound the ability to interpret data from the study,\n\n          -  any serious medical condition, laboratory abnormality, or psychiatric illness, that\n             would prevent the subject from signing the Informed Consent Form,\n\n          -  pregnant or lactating females,\n\n          -  other severe conditions, which makes the patient unsuitable to participate in the\n             study, as judged by the Investigator,\n\n          -  the patient is active in another clinical trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 18, 2012", 
        "firstreceived_results_date": "July 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01687036", 
            "org_study_id": "CoolLoop First"
        }, 
        "intervention": {
            "arm_group_label": "Cryoablation", 
            "description": "Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System", 
            "intervention_name": "Cryoablation", 
            "intervention_type": "Device", 
            "other_name": [
                "Cryoablation", 
                "Cool Loop first", 
                "Cryoablation of Atrial Fibrillation"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Atrial fibrillation", 
            "Cryoablation"
        ], 
        "lastchanged_date": "November 25, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Innsbruck", 
                        "country": "Austria", 
                        "zip": "6020"
                    }, 
                    "name": "Medical University Innsbruck"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Linz", 
                        "country": "Austria", 
                        "zip": "4020"
                    }, 
                    "name": "AKH Linz"
                }
            }
        ], 
        "location_countries": {
            "country": "Austria"
        }, 
        "number_of_arms": "1", 
        "official_title": "Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System", 
        "overall_official": {
            "affiliation": "Medical University Innsbruck", 
            "last_name": "Markus Stuehlinger, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Austria: Federal Office for Safety in Health Care", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "The primary study objective is assessed by recording all Serious Adverse Events (SAEs).\nPrimary endpoint: measurement of the following parameters:\ndeformation of the catheter loop resulting in entrapment of the catheter in the heart and difficulties removing the catheter during visit 3 (treatment).\nphrenic nerve palsy during visit 3 (treatment).\nonset and time course between visit 3 (treatment) and visit 5 (discharge) of death, pericardial tamponade, valve damage requiring surgery and hemorrhage requiring transfusion.\nonset and time course between visit 3 (treatment) and visit 9 (final visit) of atrioesophageal fistula, sepsis, abscesses, endocarditis, stroke, transient ischemic attack, and PV stenosis requiring intervention.", 
                "measure": "Safety of Ablation Using the AFreeze Cryoablation System Consisting of the CoolLoop\u00ae Ablation Catheter, Its Steerable Sheath and the Cryoconsole Cryo-Caddy Assessed by Recording All Serious Adverse Events (SAEs)", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }, 
            {
                "description": "The primary study objective is assessed by recording all Adverse Events (AEs).\nPrimary endpoint: measurement of the following parameters:\n- deformation of the catheter loop resulting in entrapment of the catheter in the heart and difficulties removing the catheter during visit 3 (treatment).", 
                "measure": "Tolerability of Ablation Using the AFreeze Cryoablation System", 
                "safety_issue": "Yes", 
                "time_frame": "Treatment Duration"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01687036"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Feasibility, defined by the ability to position the catheter in the proximal part in each of the pulmonary veins (PVs) using an over-the-wire technique, forming the cryo-applicator of the catheter to a loop by operating the catheter handle, positioning the loop at the wall of the PV antrum and delivering cryothermia.", 
                "measure": "Feasibility of Catheter Ablation Measured by Number of Participants Treated With the AFreeze Cryoablation System.", 
                "safety_issue": "No", 
                "time_frame": "Treatment Duration"
            }, 
            {
                "description": "Absolute percentage of PVs isolated with the CoolLoop\u00ae catheter.", 
                "measure": "Acute Efficacy of Catheter Ablation", 
                "safety_issue": "No", 
                "time_frame": "Treatment Duration"
            }, 
            {
                "description": "During follow-up recurrence of AF was reported by the patient and documented by ECG in 8 patients (80%). 2 patients remained free of recurrences of AF.", 
                "measure": "Clinical Efficacy of Catheter Ablation", 
                "safety_issue": "No", 
                "time_frame": "First patient - first visit: September 11, 2012; Last patient - last visit: March 26, 2013"
            }, 
            {
                "description": "Procedure time was defined from introduction of the CoolLoop\u00ae catheter into the left atrium until removal of the CoolLoop\u00ae catheter from the left atrium after termination of the last cryo-application.", 
                "measure": "Procedure Time", 
                "safety_issue": "No", 
                "time_frame": "Average procedure time: 251 min. 06 sec. (range 126 - 320 min.)"
            }, 
            {
                "description": "Fluoroscopy time was defined from introduction of the CoolLoop\u00ae catheter into the left atrium until removal of the CoolLoop\u00ae catheter from the left atrium after termination of the last cryo - application. Accumulated time using fluoroscopy during procedure time.\nAverage fluoroscopy time was 44 min. 01 sec. (range 17 min. 03 sec. - 59 min.).", 
                "measure": "Fluoroscopy Time", 
                "safety_issue": "No", 
                "time_frame": "Treatment Duration"
            }, 
            {
                "description": "Cryoablation time was defined as the cumulative duration of all cryoapplications in each single study patient.\nAverage cryoablation time was 114 min. 33 sec. (range 80 - 130 min.).", 
                "measure": "Cumulative Cryoablation Time", 
                "safety_issue": "No", 
                "time_frame": "First patient - first visit: September 11, 2012; Last patient - last visit: March 26, 2013"
            }, 
            {
                "description": "18 AEs were recorded in 7 out of 10 patients. 3 AEs were definitely related to treatment and one AE was definitely device related. All patients recovered completely.", 
                "measure": "AE", 
                "safety_issue": "Yes", 
                "time_frame": "First patient - first visit: September 11, 2012; Last patient - last visit: March 26, 2013"
            }
        ], 
        "source": "AFreeze GmbH", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AFreeze GmbH", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}